HOME › DRUGS › PROPOXYPHENE NAPSYLATE
ACTIVE SUBSTANCE / INN

PROPOXYPHENE NAPSYLATE

Brand name(s): PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN, PROPACET 100, DARVOCET-N 50, DARVON-N W/ ASA, DARVOCET A500, DARVOCET-N 100, DARVON-N
FDA LISTED
DISCONTINUED
NDA016863
NDA017122
ACTIVE SUBSTANCE
Propoxyphene Napsylate
REGULATORS
FDA
SPONSORS / MAH
TEVA, MUTUAL PHARM, XANODYNE PHARM
TOTAL APPLICATIONS
7
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
DARVOCET A500ANDA076429XANODYNE PHARMDiscontinued
PROPOXYPHENE NAPSYLATE AND ACETAMINOPHENANDA070115MUTUAL PHARMDiscontinued
DARVON-N W/ ASANDA016863AAIPHARMA LLCDiscontinued
DARVOCET-N 50NDA017122XANODYNE PHARMDiscontinued
DARVOCET-N 100NDA017122XANODYNE PHARMDiscontinued
DARVON-NNDA016861AAIPHARMA LLCDiscontinued
PROPACET 100ANDA070107TEVADiscontinued

FULL INTELLIGENCE ON PROPOXYPHENE NAPSYLATE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →